Dr. Prashanth LK
Dr. Prashanth LK is a prominent neurologist and Parkinson’s disease specialist based in Bangalore, India, where he currently runs an exclusive Parkinson’s Disease and Movement Disorders Clinic. Dr. Prashanth LK has completed Bachelor’s degree from Mahadevappa Rampure Medical college, Gulbarga University (1995-2001), and residency in Neurology from National Institute of Mental Health and Neurosciences (NIMHANS, Deemed University) (2003-2008). With a clinical movement disorders fellowship under Prof. Anthony Lang and a surgical movement disorders fellowship under Prof. Elena Moro, Dr. Prashanth has developed a keen interest in genetics of movement disorders, continuous dopaminergic stimulation therapies (Apomorphine / DBS), Botulinum toxin therapies, and Wilson’s disease.
He is a founding member of the Movement Disorders Society of India (MDSI), and has been active in various positions including website editor, executive committee member, and currently the treasurer of the society. Dr. Prashanth is also an active member of the International Parkinson and Movement Disorders Society (IPMDS), serving on the board of ‘Movement Disorders in Clinical Practice (MDCP)’ journal, ‘Deep Brain Stimulation’ journal, ‘Moving Along’ newsletter, and the ‘Web Editorial Board’. Additionally, he is currently an executive committee member of the Asian and Oceanic section of the IPMDS, and a member of MDS AOS regional Task Force on Movement Disorders in Asia.
Dr. Prashanth is an active member of Parkinson Research Alliance of India (PRAI) and is the principal investigator for pan India study on Genetics of Young Onset Parkinson’s Disease (GOPI-YOPD) and Pan India Registry of Progressive Supranuclear Palsy (PAIR-PSP). He is also a steering committee member of the Global Parkinson’s Genetics Program (GP2), which aims to facilitate the understanding of the genetic architecture of PD across the globe. He is also working in tandem with various researchers in India for varied projects, some of them include Genome Wide Association study on Parkinson’s disease in India, patterns of movement disorders in India etc. He is a taskforce member on Wilson’s disease in India, which is a collaboration of INASL (Indian National Association for the Study of the Liver), Movement Disorders Society of India (MDSI) and ISPGHAN (Indian Society of Pediatric Gastroenterology, Hepatology and Nutrition). Dr. Prashanth has multiple publications in various national and international journals over the last two decades with impressive impact factors.
Consultant Neurologist & Movement Disorders Specialist
Specialist: Parkinson’s Disease and Other related Movement Disorders.
Founding Member: Movement Disorders Society of India
Steering Committee Member : Global Parkinson’s Genetics Program (2023-__)
Executive committee Member : Asian & Oceanian Section of IPMDS (MDS-AOS) (2021-2025)
Treasurer : Movement Disorders Society of India (2021-2024)
Web Editor : Movement Disorders Society of India (2014-2021)
Editorial Board : Moving Along Newsletter of International Parkinson and Movement Disorder Society (IPMDS)
Editorial Board : Movement Disorders in Clinical Practice Journal (MDCP) (2022-__)
Editorial Board : Deep Brain Stimulation Journal (2022 -)
Publications
2. Sinha S, Taly AB, Prashanth LK, Arunodaya GR, Swamy HS. Successful pregnancies and abortions in symptomatic and asymptomatic Wilson’s disease. J Neurol Sci 2004;217(1):37-40.
3. Prashanth LK, Taly AB, Sinha S, Arunodaya GR, Swamy HS. Wilson’s disease: diagnostic errors and clinical implications. J Neurol Neurosurg Psychiatry 2004;75(6):907-909
4. Sinha S, Prashanth LK, Mahadevan A, Satish S, Ravishankar S, Arunodaya GR, et al. Co-occurrence of Wilson’s disease and glioblastoma multiforme–is it a chance association? Clin Neuropathol 2004;23(5):241-244.
5. Meenakshi-Sundaram S, Sinha S, Rao M, Prashanth LK, Arunodaya GR, Rao S, et al. Cardiac involvement in Wilson’s disease–an electrocardiographic observation. J Assoc Physicians India 2004;52:294-296.
6. Sinha S, Ravishankar S, Taly AB, Arunodaya GR, Prashanth LK, Vasudev MK. Wilson’s disease: A 31P and 1H MR spectroscopic study. Neurology 2004; 62(5): 539-540.
7. Sinha S, Christopher R, Prashanth LK, Vidya N, Arunodaya G R, S Rao, Taly AB. Malonialdhyde levels in Wilson’s disease? Annals of Indian Academy of Neurology, 2004;7(4):507-510.
8. Prashanth LK, Sinha S. Pupil. Chakravorty A(ed) In Neurophthalmology. Journal of Association of eastern India, Kolkata, 2004: 406-423.
9. Sinha S, Christopher R, Arunodaya GR, Prashanth LK, Gopinath G, Swamy HS, et al. Is low serum tocopherol in Wilson’s disease a significant symptom? J Neurol Sci 2005;228(2):121-123.
10. Prashanth LK, Taly AB, Sinha S, Ravishankar S, Arunodaya GR, Vasudev MK, et al. Prognostic factors in patients presenting with severe neurological forms of Wilson’s disease. QJM 2005;98(8):557-563.
11. Prashanth LK, Taly AB, Sinha S, Arunodaya GR, Swamy HS. Wilson’s disease: Diagnostic errors and clinical implications. Psychiatric review 2005; 5: 91-93.
12. Prashanth LK, Taly AB, Ravi V, Sinha S, Arunodaya GR. Adult onset subacute sclerosing panencephalitis: clinical profile of 39 patients from a tertiary care centre. J Neurol Neurosurg Psychiatry 2006;77(5):630-633.
13. Prashanth LK, Taly AB, Ravi V, Sinha S, Rao S. Long term survival in subacute sclerosing panencephalitis: an enigma. Brain Dev 2006;28(7):447-452.
14. Sinha S, Taly AB, Ravishankar S, Prashanth LK, Venugopal KS, Arunodaya GR, et al. Wilson’s disease: cranial MRI observations and clinical correlation. Neuroradiology 2006;48(9):613-621.
15. Prashanth LK, Taly AB, Sinha S, Ravi V. Subacute sclerosing panencephalitis (SSPE): an insight into the diagnostic errors from a tertiary care university hospital. J Child Neurol 2007;22(6):683-688.
16. Sinha S, Taly AB, Prashanth LK, Ravishankar S, Arunodaya GR, Vasudev MK. Sequential MRI changes in Wilson’s disease with de-coppering therapy: a study of 50 patients. Br J Radiol 2007;80:744-749.
17. Sinha S, Taly AB, Ravishankar S, Prashanth LK, Vasudev MK. Central Pontine Signal Changes in Wilson Disease: Distinct MRI Morphology and Sequential Changes with De-Coppering Therapy. J of Neuroimaging. 2007; 17:286-291.
18. Shanmugiah A, Sinha S, Taly AB, Prashanth LK, Tomar M, Arunodaya GR, Janardhana Reddy YC, Khanna S. Psychiatric Manifestations in Wilson’s disease: A Cross-Sectional Analysis. J Neuropsychiatry Clin Neurosci. 2008;20:81-85.
19. Srinivas K, Sinha S, Taly AB, Prashanth LK, Arunodaya GR, Janardhana Reddy YC, S Khanna. Dominant psychiatric manifestations in Wilson’s disease: a diagnostic and therapeutic challenge! J Neurol Sci. 2008;266:104-108.
20. Komal Kumar RN, Taly AB, Nair KPS, Sinha S, Prashanth LK, Vidya N, Arunodaya GR, Rao S. Quality of Life in Wilson’s disease. Annals of Indian Academy of Neurology. 2008;11:37-43.
21. Prashanth LK, Veerendrakumar M, Gayathri N, Subbukrishna DK. How many motor unit potentials to sample in diagnostic needle EMG? Clinical Neurophysiology. 2009;120 (Suppl-1):S23-S24.
22. Veerendrakumar M, Gayathri N, Subbukrishna DK, Prashanth LK. Manual Scannin EMG study of variability of motor unit potential parameters. Clinical Neurophysiology. 2009;120 (Suppl-1):S40.
23. Taly AB, Prashanth LK, Sinha S. Wilson’s disease: An Indian perspective. Neurol India. 2009 Sep-Oct;57(5):528-40.
24. Prashanth LK, Sinha S, Taly AB, A Mahadevan, Vasudev MK, Shankar SK. Spectrum of epilepsy in Wilson’s disease with electroencephalographic, MR imaging and pathological correlates. J Neurol Sci. 2010 Apr 15;291(1-2):44-51.
25. Sinha S, Taly AB, Ravishankar S, Prashanth LK, Vasudev MK. Wilson’s disease: (31)P and (1)H MR spectroscopy and clinical correlation. Neuroradiology. 2010 Nov;52(11):977-85.
26. Prashanth LK, Sinha S, Taly AB, Vasudev MK. Do MRI features distinguish Wilson’s disease from other early onset extrapyramidal disorders? An analysis of 100 cases. Mov Disord. 2010 Apr 30;25(6):672-8.
27. Prashanth LK, Fox S, Meissner WG. l-Dopa-induced dyskinesia-clinical presentation, genetics, and treatment. Int Rev Neurobiol. 2011;98:31-54.
28. Lang AE, Prashanth LK, Ghosh S, Elahi B, Chen R. Extreme task specificity: is it dystonia or another form of motor programming abnormality? Mov Disord. 2012 Aug;27(9):1202-1203.
29. Pondal M, Marras C, Miyasaki J, Moro E, Armstrong MJ, Strafella AP, Shah BB, Fox S, Prashanth LK, Phielipp N, Lang AE. Clinical features of dopamine agonist withdrawal syndrome in a movement disorders clinic. J Neurol Neurosurg Psychiatry. 2013;84(2):130-135.
30. Fasano A, Valadas A, Bhatia KP, Prashanth LK, Lang AE, Munhoz RP, Morgante F, Tarsy D, Duker AP, Girlanda P, Bentivoglio AR, Espay AJ. Psychogenic facial movement disorders: clinical features and associated conditions. Mov Disord. 2012 Oct;27(12):1544-51.
31. Connolly BS, Prashanth LK, Shah BB, Marras C, Lang AE. A randomized trial of varenicline (chantix) for the treatment of spinocerebellar ataxia type 3. Neurology. 2012 Nov 27;79(22):2218
32. Petrovic IN, Ling H, Asi Y, Ahmed Z, Kukkle PL, Hazrati LN, Lang AE, Revesz T, Holton JL, Lees AJ. Multiple system atrophy-parkinsonism with slow progression and prolonged survival: a diagnostic catch. Mov Disord. 2012 Aug;27(9):1186-90.
33. Chan HF, Kukkle PL, Merello M, Lim SY, Poon YY, Moro E. Amantadine improves gait in PD patients with STN stimulation. Parkinsonism Relat Disord. 2013 Mar;19(3):316-9.
34. Ramana Reddy AM, Prashanth LK, Sharat Kumar GG, Chandana G, Jadav R. Over-the-counter self-medication leading to intracranial hypertension in a young lady. J Neurosci Rural Pract. 2014 Oct;5(4):384-6.
35. Ling H, Asi YT, Petrovic IN, Ahmed Z, Prashanth LK, Hazrati LN, Nishizawa M, Ozawa T, Lang A, Lees AJ, Revesz T, Holton JL. Minimal change multiple system atrophy: An aggressive variant? Mov Disord. 2015 Jun;30(7):960-7
36. Prashanth LK, Murugan S, Kamath V, Gupta R, Jadav R, Sreekantaswamy S, Ramprasad VL. First report of Kufor-Rakeb Syndrome (PARK 9) from India, and a Novel Nonsense Mutation in ATP13A2 gene. Mov Disord Clin Pract. 2015 May 9;2(3):326-327
37. Cury RG, Kalia SK, Shah BB, Jimenez-Shahed J, Prashanth LK, Moro E. Surgical treatment of dystonia. Expert Rev Neurother. 2018 Expert Rev Neurother. 2018 Jun;18(6):477-492
38. Aabha Nagral, Moinak S. Sarma, John Matthai, Prashanth L. Kukkle, Harshad Devarbhavi, Sanjib Sinha, Seema Alam, Ashish Bavdekar, Radha K. Dhiman, Chundamannil E. Eapen, Vinay Goyal, Neelam Mohan, Rukmini M. Kandadai, Malathi Sathiyasekaran, Ujjal Poddar, Anupam Sibal, Srinivas Sankaranarayanan, Anshu Srivastava, Baburam R. Thapa, Pettarusp M. Wadia, Surendra K. Yachha, Anil Dhawan. Wilson’s Disease: Clinical Practice Guidelines of the Indian National Association for Study of the Liver, the Indian Society of Pediatric Gastroenterology, Hepatology and Nutrition, and the Movement Disorders Society of India. Journal of Clinical and Experimental Hepatology. 2019;9(1):74 – 98
39. Kukkle PL, Park HK, Obaid MT, Fujioka S. The chronicles of modern movement disorders in India. Ann Mov Disord 2019;2:1-8.
40. G. Kumar, P. Wadia, H. Kumar, P. K, S. Gupta, V. Goyal, A. Raza, A. Zuzek, A. Patel. Practice Patterns with Onabotulinum Toxin-A for Movement disorders: South Asian Neurologist Survey. Movement Disorders. 2019;34(S2):55.
41. P. Kukkle, V. Goyal, R. Kandadai, R. Borgohain, H. Kumar, A. Mukherjee, A. Biswas, S. Das, U. Muthane, S. Desai, P. Wadia, P. Pal, R. Yadav, V. Ramprasad. Genetics of Parkinson’s in India – Young Onset Parkinson’s Disease (GOPI-YOPD) – A Preliminary Demographic profile. Movement Disorders. 2019;34(S2):288-89
42. P. Kukkle. Movement Disorders Spectrum in a Private Practice setup in India : A 7 Year Study. Movement Disorders. 2019;34(S2):748-49
43. B. Shetty, S. Mittal, P. Kukkle. Knowledge, Attitude and Practices about Movement Disorders in India. Movement Disorders. 2019;34(S2):757-58.
44. Raju S, Ravi A, Prashanth LK. Cervical Dystonia mimics: A case series and review of literature. Tremor Other Hyperkinet Mov. 2019;9. Doi: 10.7916/tohm.v0.707
46. Prashanth LK, Jayachandran R, Raghavendra seetharam, Rajesh B Iyer. Apomorphine: The initial Indian experience in relation to response tests and pumps. Ann Indian Acad Neurol. 2020;23(1):20–4
47. Prashanth L K, Jayachandran R, Ragavendra S, Iyer RB. Looking beyond the fog—apomorphine demystified. Ann Indian Acad Neurol 2020;23:363-4
48. Prashanth LK, Thenral SG, Mahadevan A, Ramprasad VL. A case of Autosomal Dominant Ataxia with Vocal cord palsy due to mutation in PRNP gene. Mov Disord Clin Pract. 2020 Mov Disord Clin Pract. 2020 Jul 27;7(6):688-692. doi: 10.1002/mdc3.12999
49. Rajan R, Divya KP, Kandadai RM, Yadav R, Satagopam VP, Madhusoodanan UK, Agarwal P, Kumar N, Ferreira T, Kumar H, Sreeram Prasad AV, Shetty K, Mehta S, Desai S, Kumar S, Prashanth LK, Bhatt M, Wadia P, Ramalingam S, Wali GM, Pandey S, Bartusch F, Hannussek M, Krüger J, Kumar-Sreelatha A, Grover S, Lichtner P, Sturm M, Roeper J, Busskamp V, Chandak GR, Schwamborn J, Seth P, Gasser T, Riess O, Goyal V, Pal PK, Borgohain R, Krüger R, Kishore A, Sharma M and the Lux-GIANT Consortium. Genetic Architecture of Parkinson’s Disease in the Indian Population: Harnessing Genetic Diversity to Address Critical Gaps in Parkinson’s Disease Research. Front. Neurol. 2020;11:524. doi: 10.3389/fneur.2020.00524
50. Metta V, Borgohain R, L Kukkle P, Mridula R, Agarwal P, Kishore A, Goyal V, Chaudhuri R. Subcutaneous apomorphine in advanced Parkinson’s disease and its use in Indian population. Ann Mov Disord 2020;3:145-55
51. Kukkle PL, Hoskere Sreenivasa DK, Krishnan S, Ramachandran J, Seetharam R, Iyer RB. Does Apomorphine Have an Effect on Body Weight? An Observational Study. Can J Neurol Sci. 2020 Jul 29:1-4. doi: 10.1017/cjn.2020.165.
52. Kumar N, Gupta R, Kumar H, Mehta S, Rajan R, Kumar D, Kandadai RM, Desai S, Wadia P, Basu P, Mondal B, Juneja S, Rawat A, Meka SS, Mishal B, Prashanth LK, Srivastava AK, Goyal V. Impact of home confinement during COVID-19 pandemic on sleep parameters in Parkinson’s disease. Sleep Med. 2021 Jan;77:15-22. doi: 10.1016/j.sleep.2020.11.021
53. Kumar N, Gupta R, Kumar H, Mehta S, Rajan R, Kumar D, Kandadai RM, Desai S, Wadia P, Basu P, Mondal B, Sanchita, Rawat A, Meka SS, Mishal B, Prashanth LK, Srivastava AK, Goyal V. Impact of home confinement during COVID-19 pandemic on Parkinson’s disease. Parkinsonism Relat Disord. 2020 Nov;80:32-34. doi: 10.1016/j.parkreldis.2020.09.003.
54. Faisal M and Kukkle PL, Hypoparathyroidism Masquerading as Corticobasal Syndrome. Mov Disord Clin Pract; 2021: https://doi.org/10.1002/mdc3.13182
55. Raju S, Kukkle P. Huntington’s disease: The Indian perspective. Ann Mov Disord 2021;4:4-9.
56. Prabhakara S, Hanumantha Rao HM, Prashanth LK, Anbazhagan K, Jacques R, Reddy BK. PRRT2 Gene Mutations in Indian Paroxysmal Kinesigenic Dyskinesia Patients. Ann Indian Acad Neurol. 2021 May-Jun;24(3):425-429. doi: 10.4103/aian.AIAN_417_20
57. van Wamelen DJ, Sauerbier A, Leta V, Rodriguez-Blazquez C, Falup-Pecurariu C, Rodriguez-Violante M, Rizos A, Tsuboi Y, Metta V, Bhidayasiri R, Bhattacharya K, Borgohain R, Prashanth LK, Rosales R, Lewis S, Fung V, Behari M, Goyal V, Kishore A, Lloret SP, Martinez-Martin P, Chaudhuri KR. Cross-sectional analysis of the Parkinson’s disease Non-motor International Longitudinal Study baseline non-motor characteristics, geographical distribution and impact on quality of life. Sci Rep. 2021 May 5;11(1):9611. doi: 10.1038/s41598-021-88651-4. PMID: 33953218
58. GP2: The Global Parkinson’s Genetics Program. Mov Disord, 2021;36: 842-851. https://doi.org/10.1002/mds.28494
59. Prashanth LK, Hrishikesh Kumar, Pettarusp M Wadia, Muthane U. The Spectrum of movement disorders in tertiary care centers in India : A tale of three cities. Ann Indian Acad Neurol. 2021 Sep-Oct;24(5):721-725. doi: 10.4103/aian.AIAN_1257_20.
60. Kumar N, Prashanth LK, Goyal V. Wilson’s Disease: An Indian Perspective. Ann Indian Acad Neurol 2021. (doi: 10.4103/aian.AIAN_171_21)
61. Abbas MM, Thenral SG, Ramprasad VL, Walker RH, Kukkle PL. Chorea-acanthocytosis: 3 New Families with Novel Genetic and Metabolic Findings. Ann Indian Acad Neurol. 2021 May-Jun;24(3):452-456. doi: 10.4103/aian.AIAN_215_20. Epub 2021 Mar 27. PMID: 34447025; PMCID: PMC8370142.
62. Kukkle PL, Goyal V, Geetha TS, Mridula KR, Kumar H, Borgohain R, Mukherjee A, Wadia PM, Yadav R, Desai S, Kumar N, Gupta R, Biswas A, Pal PK, Muthane U, Das SK, Quinn N, Ramprasad VL; Parkinson Research Alliance of India (PRAI). Clinical Study of 668 Indian Subjects with Juvenile, Young, and Early Onset Parkinson’s Disease. Can J Neurol Sci. 2022 Jan;49(1):93-101. doi: 10.1017/cjn.2021.40. Epub 2021 Mar 9. PMID: 33685545.
63. Olszewska DA, Shetty R, Geetha TS, Ramprasad VL, Lang AE, Kukkle PL. Oculogyric Crisis Phenotype of Levodopa-Induced Ocular Dyskinesia. Mov Disord Clin Pract. 2022 Feb 10;9(3):390-393. doi: 10.1002/mdc3.13416. PMID: 36989007; PMCID: PMC8974885.
64. Metta V, Leta V, Mrudula KR, Prashanth LK, Goyal V, Borgohain R, Chung-Faye G, Chaudhuri KR. Gastrointestinal dysfunction in Parkinson’s disease: molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantation. J Neurol. 2022 Mar;269(3):1154-1163. doi: 10.1007/s00415-021-10567-w. Epub 2021 Apr 21. PMID: 33881598.
65. Kukkle PL. COVID-19: The cynosure of rise of Parkinson’s disease. Int Rev Neurobiol. 2022;165:251-262. doi: 10.1016/bs.irn.2022.06.007. Epub 2022 Jul 22. PMID: 36208903; PMCID: PMC9303069.
66. Schumacher-Schuh AF, Bieger A, Okunoye O, Mok KY, Lim SY, Bardien S, Ahmad-Annuar A, Santos-Lobato BL, Strelow MZ, Salama M, Rao SC, Zewde YZ, Dindayal S, Azar J, Prashanth LK, Rajan R, Noyce AJ, Okubadejo N, Rizig M, Lesage S, Mata IF; Global Parkinson’s Genetics Program (GP2). Underrepresented Populations in Parkinson’s Genetics Research: Current Landscape and Future Directions. Mov Disord. 2022 Jul 22. doi: 10.1002/mds.29126.
67. Kukkle PL, Geetha TS, Chaudhary R, Sathirapongsasuti JF, Goyal V, Kandadai RM, Kumar H, Borgohain R, Mukherjee A, Oliver M, Sunil M, Mootor MFE, Kapil S, Mandloi N, Wadia PM, Yadav R, Desai S, Kumar N, Biswas A, Pal PK, Muthane UB, Das SK, Sakthivel Murugan SM, Peterson AS, Stawiski EW, Seshagiri S, Gupta R, Ramprasad VL, Prai PRAOI. Genome-Wide Polygenic Score Predicts Large Number of High Risk Individuals in Monogenic Undiagnosed Young Onset Parkinson’s Disease Patients from India. Adv Biol (Weinh). 2022 Jul 10:e2101326. doi: 10.1002/adbi.202101326.
68. Qamar MA, Rota S, Batzu L, Subramanian I, Falup-Pecurariu C, Titova N, Metta V, Murasan L, Odin P, Padmakumar C, Kukkle PL, Borgohain R, Kandadai RM, Goyal V, Chaudhuri KR. Chaudhuri’s Dashboard of Vitals in Parkinson’s syndrome: an unmet need underpinned by real life clinical tests. Front Neurol. 2023 May 25;14:1174698. doi: 10.3389/fneur.2023.1174698. PMID: 37305739; PMCID: PMC10248458.
69. Jagota P, Lim SY, Pal PK, Lee JY, Kukkle PL, Fujioka S, Shang H, Phokaewvarangkul O, Bhidayasiri R, Mohamed Ibrahim N, Ugawa Y, Aldaajani Z, Jeon B, Diesta C, Shambetova C, Lin CH. Genetic Movement Disorders Commonly Seen in Asians. Mov Disord Clin Pract. 2023 May 8;10(6):878-895. doi: 10.1002/mdc3.13737. PMID: 37332644; PMCID: PMC10272919.
70. Jost ST, Kaldenbach MA, Antonini A, Martinez-Martin P, Timmermann L, Odin P, Katzenschlager R, Borgohain R, Fasano A, Stocchi F, Hattori N, Kukkle PL, Rodríguez-Violante M, Falup-Pecurariu C, Schade S, Petry-Schmelzer JN, Metta V, Weintraub D, Deuschl G, Espay AJ, Tan EK, Bhidayasiri R, Fung VSC, Cardoso F, Trenkwalder C, Jenner P, Ray Chaudhuri K, Dafsari HS; International Parkinson and Movement Disorders Society Non-Motor Parkinson Disease Study Group. Levodopa Dose Equivalency in Parkinson’s Disease: Updated Systematic Review and Proposals. Mov Disord. 2023 May 5. doi: 10.1002/mds.29410. Epub ahead of print. PMID: 37147135.
71. Ibrahim NM, Jagota P, Pal PK, Bhidayasiri R, Lim SY, Ugawa Y, Aldaajani Z, Jeon B, Fujioka S, Lee JY, Kukkle PL, Shang H, Phokaewvarangkul O, Diesta C, Shambetova C, Lin CH. Historical and more common nongenetic movement disorders from Asia. J Mov Disord. 2023 Jun 9. doi: 10.14802/jmd.22224. Epub ahead of print. PMID: 37291830.
72. Wall JD, Sathirapongsasuti JF, Gupta R, Rasheed A, Venkatesan R, Belsare S, Menon R, Phalke S, Mittal A, Fang J, Tanneeru D, Deshmukh M, Bassi A, Robinson J, Chaudhary R, Murugan S, Ul-Asar Z, Saleem I, Ishtiaq U, Fatima A, Sheikh SS, Hameed S, Ishaq M, Rasheed SZ, Memon FU, Jalal A, Abbas S, Frossard P, Fuchsberger C, Forer L, Schoenherr S, Bei Q, Bhangale T, Tom J, Gadde SGK, B V P, Naik NK, Wang M, Kwok PY, Khera AV, Lakshmi BR, Butterworth AS, Chowdhury R, Danesh J, di Angelantonio E, Naheed A, Goyal V, Kandadai RM, Kumar H, Borgohain R, Mukherjee A, Wadia PM, Yadav R, Desai S, Kumar N, Biswas A, Pal PK, Muthane UB, Das SK, Ramprasad VL, Kukkle PL, Seshagiri S, Kathiresan S, Ghosh A, Mohan V, Saleheen D, Stawiski EW, Peterson AS. South Asian medical cohorts reveal strong founder effects and high rates of homozygosity. Nat Commun. 2023 Jun 8;14(1):3377. doi: 10.1038/s41467-023-38766-1. PMID: 37291107; PMCID: PMC10250394.
73. Jagota P, Ugawa Y, Aldaajani Z, Ibrahim NM, Ishiura H, Nomura Y, Tsuji S, Diesta C, Hattori N, Onodera O, Bohlega S, AlDin ASN, Lim SY, Lee JY, Jeon B, Pal PK, Shang H, Fujioka S, Kukkle PL, Phokaewvarangkul O, Lin CH, Shambetova C, Bhidayasiri R. Nine Hereditary Movement Disorders First Described in Asia: Their History and Evolution. J Mov Disord. 2023 Jun 13. doi: 10.14802/jmd.23065. Epub ahead of print. PMID: 37309109.
74. Akshay S, Amudha J, Kulkarni N, Prashanth LK. (2023). iSTIMULI: Prescriptive Stimulus Design for Eye Movement Analysis of Patients with Parkinson’s Disease. In: Morusupalli, R., Dandibhotla, T.S., Atluri, V.V., Windridge, D., Lingras, P., Komati, V.R. (eds) Multi-disciplinary Trends in Artificial Intelligence. MIWAI 2023. Lecture Notes in Computer Science(), vol 14078. Springer, Cham. https://doi.org/10.1007/978-3-031-36402-0_55
75. Prashanth LK, Divyani Garg, Marcello Merrello. Continuous Subcutaneous Infusion Delivery of Apomorphine in Parkinson’s Disease: A Systematic Review. Mov Disord Clin Pract. 2023 Jun 26;10(9):1253-1267. doi: 10.1002/mdc3.13810
76. Metta V, Dhamija RK, Batzu L, Mrudula R, Kumar NSS, S A, Falup-Pecurariu C, Rodriguez-Blazquez C, Goyal V, L K P, Bhattacharya K, Kumar S, Chaudhuri KR, Borgohain R. Safety and tolerability of long-term apomorphine infusion in advanced Parkinson’s disease: an Indian multi-center (APO-IND) experience. Sci Rep. 2023 Oct 31;13(1):18681. doi: 10.1038/s41598-023-46003-4.
77. The genetic drivers of juvenile, young, and early-onset Parkinson’s Disease in India. Movement Disorders Journal (Accepted) doi:10.1002/mds.29676
Invited Faculty
2. Invited speaker for Physcian Update held at Ahemdabad between 16-17th June 2012
3. Teaching faculty for AOS-MDS Teaching program held at AIIMS, New Delhi, 27th – 28th October 2012
4. Teaching faculty for Botulinum toxin Workshop for the neurologists of Salem, April 2013
5. Invited Speaker for the Movement Disorders symposium at the Annual Conference of Indian Academy of Neurology held at Indore, October 2013.
6. Teaching Faculty for Botulinum Workshop at Christian Medical College, Vellore, November 2013.
7. Invited faculty to conduct Botulinum Workshop for the Karnataka Neurological Association Conference to be held at Shimoga – 14- 16 February 2014.
8. Invited Speaker on “Myoclonus – A Clinical Approach” at ‘International Update on Movement Disorders’ being held at Siliguri, West Bengal between 14-16th February 2014.
9. Teaching Faculty for Hypokinetic Disorders, A video based approach as part of SHINE 2014, Chennai 4th-6th 2014.
10. Guest Speaker on ‘Deep Brain Stimulation (DBS) – Role of Neurologist’ on April 27th 2014, at NSI Karavali Chapter, Mangalore.
11. Invited speaker at 2nd Movement Disorders Update of I-NK, & Workshop on Botulinum Toxin Injection held at Kolkatta August 2014.
12. Invited speaker for 1st Movement disorder symposium cum workshop at Patna on 14th Nov, 2014
13. Guest speaker on “Movement Disorders – For Physcians” at Bangalore Neuro Education trust meet, held on 15-16 November 2014, Bangalore.
14. Invited speaker on ‘Approach to movement Disorders’ at Apollo Neurosciences meet, 7th December 2014, Bangalore.
15. Invited speaker on “Movement Disorders in Demyelinating Diseases” at First CME of Movement Disorders Society of India, 3rd – 4th January, 2015, New Delhi.
16. Invited speaker on “Management of Advanced Parkinson’s Disease” at Karnataka Neuroscience Association Conference, held at Mangalore,2 20th – 22nd February 2015
17. Teaching Faculty for Movement Disorders Video Session at SHINE 2015, Chennai, 6th-8th , March 2015.
18. Invited Speaker on “Hemifacial Spasm” and “Blepharospasm” at Botulinum Workshop, Goa, June 2015.
19. Invited Speaker on “Approach to Tremors” and ‘Hands on Botulinum Workshop’ at Movement Disorders CME, Ahmedabad, 2015.
20. Invited Speaker on “Parkinson’s Disease” in IAN Neurology Education for Physicians at Bangalore, September 2015.
21. Invited Speaker on ‘Overview of Movement Disorders’ Association of Family Physcians meet at Bangalore, October 2015
22. Invited Speaker on ‘Management of Parkinson’s Disease’ at 2nd Bangalore Neuro Update, at Bangalore, November 2015
23. Invited speaker on ‘Management of Parkinson’s Disease’ at 2nd Apollo Neurosciences meet, 6th December 2015, Bangalore.
24. Teaching Faculty for ‘Botulinum Toxin for Cervical Dystonia’ at 1st Movement Disorders Society of India Conference, Chennai, January 2016.
25. Invited Faculty and Organizer for ‘Video Akhada’, at 1st Movement Disorders Society of India Conference, Chennai, January 2016.
26. Teaching Faculty for ‘Botulinum Workshop’ at Karnataka Neurosciences Asscoiation conference (KNACON) held at Gulbarga, January 2016.
27. Invited Speaker on ‘Surgical Patient Selection for Deep Brain Stimulation : Case scenarios”, MEDTRONIC DBS Meet, Hyderbad, February 2016.
28. Invited Speaker on ‘Post DBS Surgical Programming”, MEDTRONIC DBS Meet, Hyderbad, February 2016.
29. Invited Speaker on ‘Hemifacial Spasm’ and ‘Blepharospasm’ at INK Movement Disorders Meet, Kolkatta, March 2016
30. Teaching Faculty for ‘Movement Disorders Video Session’ at SHINE 2016, Chennai, 6th-8th , March 2016.
31. Invited Speaker on ‘Deep Brain Stimulation: Patient Selection Process”, MEDTRONIC DBS Meet, Hubli, June 2016.
32. Invited Speaker on ‘Post DBS Surgical Programming”, MEDTRONIC DBS Meet, Hubli, June 2016.
33. Invited Speaker on ‘Overview of Movement Disorders and Parkinson’s Disease’ at Mysore Apollo Neuroscience CME at Mysore, June 2016.
34. Invited Speaker on ‘Childhood Dystonias and Rheumatic chorea’ at Pediatric Movement Disorders Meet, at NIMHANS, June 2016.
35. Invited Speaker on ‘Deep Brain stimulation- A Surgical journey’ at INFOSYS, Bangalore, July 2016.
36. Invited Speaker on ‘Intresting Clinical cases in Parkinsonism’ at FINE Weekend Movement Disorders Program at Mumbai, August 19-21, 2016.
37. Invited Speaker on ‘Drug Induced Movement Disorders’ at 1st Brain and Mind meet, Chennai, August, 27, 2016.
38. Invited Speaker on ‘Approach to Hyperkinetic Movement Disorders’ at Basics of Movement Disorders Meet, Chennai, September 26, 2016.
39. Invited Speakder on ‘Autoimmune Neurological Disorders’, at 38th Annual CME in Internal Medicine held under the aegis of Medical Education and research trust (MERT), Bangalore, October 2016.
40. Invited speaker on ‘Movement Disorders Video Session’ at 3rd Bangalore Neuroupdate, Bangalore, November 2016
41. Invited Speaker on ‘Understanding Neuromodulation’ at 3rd Apollo Neurosciences meet, Bangalore, December 2016.
42. Invited speaker on ‘Uses of Botulinum in Neurology’ at 3rd Apollo Neurosciences meet, Bangalore, December 2016.
43. Invited Speaker on ‘Autoimmune Movement Disorders’ at 2nd Movement Disorders Society of India Conference (MDSICON), Bangalore, January 6-8, 2017.
44. Invited Faculty and Organizer for ‘Video Akhada’, at 2nd Movement Disorders Society of India Conference (MDSICON), Bangalore, January 6-8, 2017.
45. Invited Faculty for ‘Medical management of Parkinson’s Disease’ at Karnataka Neuroscienes Association Conference, Bagalkot, January 28-29, 2017.
46. Invited Faculty on ‘Overview of Parkinson’s Disease & Parkinsonism’ at STEP 2017, Bangalore, February 4, 2017
47. Invited Faculty for ‘Movement Disorders Video Session’ at SHINE 2017, Chennai, February 24-26th, 2017.
48. Organizer for ‘SHINE Video session’ at SHINE 2017, Chennai, February 24-26th, 2017.
49. Invited Faculty for ‘How do I diagnose Neuro Wilson disease at the bedside?’ at ‘Wilson Disease – Bench to the Bedside’, HEPATICON 2017 at Mumbai, March 25, 2017.
50. Invited Faculty for ‘Panel discussion on Management of Neuro-hepatic Wilson disease – worsened on d-Penicillamine. Discussion beyond drugs – Botox, Physiotherapy, diet and neuro drugs’, at ‘Wilson Disease – Bench to the Bedside’, HEPATICON 2017 at Mumbai, March 25, 2017.
51. Invited Faculty for ‘Panel discussion on developmental, speech, pschiatric and counseling issues in Wilson’s Disease’, at ‘Wilson Disease – Bench to the Bedside’, HEPATICON 2017 at Mumbai, March 25, 2017.
52. Invited Faculty for ‘Overview of Movement Disorders’ at Jawahar Lal Nehru Medcial College (JNMC) Scientific Society Annual CME, Belgaum, April 8-9th, 2017.
53. Invited Faculty for ‘Treatment of Parkinson’s Disease’ at Jawahar Lal Nehru Medcial College (JNMC) Scientific Society Annual CME, Belgaum, April 8-9th, 2017.
54. Teaching Faculty for ‘Botulinum Toxin Workshop’ at 25th Annual Indian Academy of Neurology Conference (IANCON), Chennai, September 2017.
55. Invited Speaker on ‘Overview of Movement Disorders, at 39th Annual CME in Internal Medicine held under the aegis of Medical Education and research trust (MERT), Bangalore, October 2017.
56. Invited Speaker on ‘Emergencies in Movement Disorders’, at 4th Bangalore Neuro Update, held under the aegis of Bangalore Neuro Education trust, Bangalore, November 2017.
57. Invited Speaker on ‘Anatomy of Cervical Muscles’, at The Art and Science of Botulinum, meet on 26th November 2017, Bangalore.
58. Invited Speaker on ‘Management of Parkinson’s disease’ at 4th Apollo Neurosciences meet, Bangalore, December 2016.
59. Invited Speaker on ‘Whats Hot in PD in 2017? Critical review of publications”at 3rd Movement Disorders Society of India Conference (MDSICON), Hyderabad, January 19-21, 2018.
60. Invited Faculty and Organizer for ‘Video Akhada’, at 3rd Movement Disorders Society of India Conference (MDSICON), Hyderabad, January 19-21, 2018.
61. Invited Faculty for ‘Emergencies in Movement Disorders’ at Karnataka Neuroscienes Association Conference, Hubli, January 26-27, 2018.
62. Invited Faculty for ‘Movement Disorders Video Session’ at SHINE 2017, Chennai, February 23rd-25th, 2018.
63. Organizer for ‘SHINE Video session’ at SHINE 2017, Chennai, February 23rd-25th, 2018.
64. Invited Faculty for “Approach to Parkinsonism” at Davanegere Neuroupdate, March 10-11, 2018
65. Invited Factulty for ‘Treatability in Wilson’s Disease – An overhyped Concept?’ at 4th Movement Disorders Update of Institute of Neurosciences Kolkata, held at Kolkata, April 7-8th, 2018.
66. Arbiter for the ‘Movement Disorders Video Session’ at 4th Movement Disorders Update of Institute of Neurosciences Kolkata, held at Kolkata, April 7-8th, 2018.
67. Invited Speaker on ‘Approach to tremors”, at 5th Bangalore Neuro Update, held under the aegis of Bangalore Neuro Education trust, Bangalore, November 2018
68. Invited Speaker on ‘Tics and Stereotypies – Are they the same?”at 4th Movement Disorders Society of India Conference (MDSICON), New Delhi, February 21-23, 2019.
69. Invited Faculty and Organizer for ‘Video Akhada’, at 4th Movement Disorders Society of India Conference (MDSICON), New Delhi, February 21-23, 2019.
70. Invited Faculty for ‘Movement Disorders Video Session’ at SHINE 2019, Chennai, February 21st-23rd, 2019.
71. Organizer for ‘SHINE Video session’ at SHINE 2019, Chennai, February 23rd-25th, 2019
72. Invited Faculty for ‘Approach to Dystonia’ at Mid-term Association of Neuroscientists of Eastern India (ANEICON), Siliguri, July, 2019
73. Invited Faculty for ‘Treatable Movement Disorders’ at National Movement Disorders Conclave, Uttarakhand, Rishikesh, July 14th- 15th, 2019
74. Invited Faculty for ‘Management of Parkinson’s Disease’ at World Neurosciences Summit 2019, New Delhi, August 24th-25th, 2019
75. Invited Faculty for ‘Sporadic Adult Onset Ataxias’ at The 3D Approach to Movement Disorders, Chennai, August 29th-31st , 2019
76. Invited Faculty for ‘Video Silambam’ at The 3D Approach to Movement Disorders, Chennai, August 29th-31st , 2019
77. Invited Faculty for ‘Management of Parkinson’s Disease including DBS’ at Thereputics in Neurology meet, Calicut, September 1st, 2019
78. Invited Faculty for ‘Approach to Programming’ in Deep Brain Stimulation in Movement Disorders, MDS Education Course, Hyderbad, November 8-10th, 2019
Presentations in Conferences
1. Sinha S, Prashnath LK, Christopher R, Rao S, Arunodaya GR, Taly AB. Is there a role of alpha tocopherol in Wilson’s disease? (Abstract) Presented at ANEICON 2002 at Patna; JANEI, Nov’ 2002.
2. Prashanth LK, Taly AB, Sinha S, Arunodaya GR, Swamy HS. Wilson’s disease: a diagnostic challenge. Presented in 21st Annual Conference of Association of Physicians of India – Karnataka chapter, from 9-11th May 2003 held at Mysore.
3. Sinha S, Vasudev MK, Taly AB, Arunodaya GR, Ravishankar S, Prasanth LK, Venugopal KS, Swamy HS. Serial MRI changes in Wilson’s disease on treatment. Presented in 55th Annual conference of Neurological Society of India, from 11th –14th Dec’ 2003 at Chandigarh.
4. Srinivas K, Sinha S, Taly AB, Arunodaya GR, Janardhan Reddy YC, Prashanth LK. Psychiatric manifestations in Wilson’s disease: A diagnostic and therapeutic challenge. Presented in 56th ANCIPS, from 7–10th January 2004 held at Mysore.
5. Prashanth LK. Wilson disease: Lessons learnt from a large cohort. Presented at National Neurosceince Conference, Bangalore, 10-12th September, 2004.
6. Prashanth LK, Taly AB, Kamath V, Ravi V, Arunodaya GR, Sinha S, Veerendrakumar M, Subhas GT. Long Term Survival In Subacute Sclerosing Panencephalitis: An Enigma. Presented in 13th Annual Conference of Indian Academy of Neurology, from 23-25th September held at Jaipur.
7. S Sinha, AB Taly, LK Prashanth, S Ravishankar, GR Arunodaya. Central Pontine Myelinolysis in Wilson Disease: MRI Morphology And Sequential Changes With De-Coppering Therapy. Presented at NEUROCON, from 15-18th 2005 December held at Vishakapatnam.
8. Prashanth LK, Taly AB, Ravi V, Sinha S, Arunodaya GR. Adult onset Subacute Sclerosing Panencephalitis. Presented at 61st Annual conference of the Association of Physicians of India, Patna, from 30th Jan to 2nd Feb 2006 held at Patna.
9. Prashanth LK, Chandrashekara P, Murthy KR, Mahesh MC. CMV retinitis in HIV infection: A profile of 12 patients. Presented at 24th Annual conference of Association of physician of India- Karnataka Chapter, from 26-28th May 2006 held at Bangalore.
10. Prashanth LK, Taly AB, Sinha S, Ravi V. A Clinical Audit of SSPE: Experience over a Decade at NIMHANS. Presented in 14th Annual Conference of Indian Academy of Neurology, from 6-8th October 2006 held at Bangalore.
11. Prashanth LK, ‘A case of Parkinsonism’, Presented in ‘Video Akhada’ of 2nd Annual Movement Disorders Society of India conference(MDSICON), Bangalore, January 6-8, 2017.
12. Prashanth LK, ‘A case of abnormal movements’, Presented in ‘Video Akhada’ of 2nd Annual Movement Disorders Society of India conference(MDSICON), Bangalore, January 6-8, 2017.
13. Prashanth LK, ‘A case of Ataxia’, Presented in ‘Video Akhada’ of 3rd Annual Movement Disorders Society of India conference(MDSICON), Hyderabad, January 19-21st, 2018.
PRESENTATIONS AT INTERNATIONAL MEETINGS
1. Sinha S, Vasudev MK, Taly AB, Arunodaya GR, Ravishankar S, Prasanth LK, Venugopal KS, HS Swamy. Wilson’s disease: Cranial MRI observations and clinical correlation in 74 patients From India. Presented in the 55th American Academy of Neurology meet, from 29th March to 5th April 2003 helad at Hawaii, USA.
2. Sinha S, Ravishankar S, Taly AB, Arunodaya GR, Prasanth LK, Vasudev MK. Wilson’s disease: A 31P and 1H MR spectroscopic study. Presented in the 56th American Academy of Neurology meet, from 24th April to 1st May 2004, held at San Francisco, USA.
3. Prasanth LK, Taly AB, Sinha S, Ravishankar S, Arunodaya GR, Vasudev MK, Swamy HS. Severe Form of Wilson’s disease: Differential Therapeutic outcome. Presented at 8th Asian and Oceanian Congress of child neurology,from 7-10th October 2004, held at New Delhi, India.
4. Prashanth LK, Sinha S, Taly AB, Mahadevan, A, Shankar SK. Seizures in Wilson’s disease: Clinical, Radiological and Pathological study. Presented at 6th Asian and Oceanian Epilepsy congress, from 16–19th November 2006, held at Kuala Lumpur, Malaysia.
5. Veerendrakumar M, Gayathri N, Subbakrishna DK, Prashanth LK, Nagaraja D. Effect of needle position on Motor unit potential parameters : A “Manual Scanning EMG” study. Presented at 12th Asian Oceanian Congress of Neurology and 16th Annual Conference of Indian Academy of Neurology, from 23rd – 26th October 2008, held at New Delhi, India.
6. Prashanth LK, Veerendrakumar M, Gayathri N, Subbukrishna DK. Relative diagnostic yield of motor unit potential parameters in limb girdle syndrome. Presented at 12th Asian Oceanian Congress of Neurology and 16th Annual Conference of Indian Academy of Neurology, from 23rd – 26th October 2008, held at New Delhi, India.
7. Prashanth LK, Sinha S, Taly AB, Vasudev MK. Do MRI Features distinguish Wilson’s disease from other early onset extrapyramidal disorders? An analysis of 100 cases. Presented at 2nd Asia and Oceanian Parkinson’s disease and movement disorders congress (AOPMC) meet held at New Delhi, India between 15th to 17th February 2009.
8. Prashanth LK, Veerendrakumar M, Gayathri N, Subbukrishna DK. How many motor unit potentials to sample in diagnostic needle EMG?. Presented at 2009 Asian Oceanian Congress of Clinical Neurophysiology, from 15th – 18th April 2009, held at Seoul, South Korea.
9. Veerendrakumar M, Gayathri N, Subbukrishna DK, Prashanth LK. Manual Scannin EMG study of variability of motor unit potential parameters. Presented at 2009 Asian Oceanian Congress of Clinical Neurophysiology, from 15th – 18th April 2009, held at Seoul, South Korea.
10. Prashanth LK. Awarness about Movement Disorders in Medical Fraternity: The fact. Presented at 17th International Conference on Parkinson’s disease and Movement disorders, from 16th to 20th June 2013, held at Sydney, Australia.
11. Sneha BS, Karthikbabu, Syed N, Prashanth LK. Effects of trunk Proprioceptive Neuromuscular Facilitation on Dynamic Balance, Mobility and Quality of Life in Parkinson’s Disease. Presented at 1st Annual Conference of Movement Disorders Society of India, From January 8th – 10th, 2016, Chennai, Bangalore.
12. Sneha BS, Karthikbabu, Syed N, Prashanth LK. Effects of trunk Proprioceptive Neuromuscular Facilitation on Dynamic Balance, Mobility and Quality of Life in Parkinson’s Disease. (P2.014) Presented at 21st World Congress on Parkinson’s Disease and Related Disorders. Dec 6th – 9th, 2016, Milan, Italy.
13. Prashanth LK, Presented in ‘Video Challenge’ of 21st Annual Conference of International Parkinson and Movement Disorder Society, Vancouver, Canada, June 4-8th, 2017.
14. Prashanth LK, Presented in ‘Video Challenge’ of 22nd Annual Conference of International Parkinson and Movement Disorder Society, HongKong, October 5-9, 2018.